| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |